Citation Impact
Citing Papers
Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
2012
Forecasting the Impact of Heart Failure in the United States
2013 Standout
Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)
2013
Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer
2011
Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation
2008
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
2010
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
2010
Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations
2014
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
2016
Risk Prediction in Patients With Heart Failure
2014
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
2013
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
2011
Pharmacokinetic and Pharmacodynamic Characteristics of Single-dose Canakinumab in Patients With Type 2 Diabetes Mellitus
2014
High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial
2014
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
2008
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Safety of Aggressive Lipid Management
2007
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
2012 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
Interventions to improve the appropriate use of polypharmacy for older people
2012
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology
2007
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
B-type Natriuretic Peptide-guided Chronic Heart Failure Therapy: A Meta-analysis of 11 Randomised Controlled Trials
2013
Effective Heart Disease Prediction Using Hybrid Machine Learning Techniques
2019 Standout
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction
2011
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Risk Prediction Models for Mortality in Ambulatory Patients With Heart Failure
2013
Clinical consequences of polypharmacy in elderly
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Inflammation in Atherosclerosis
2012 Standout
Combination of calcium channel blockers and β‐adrenoceptor blockers for patients with exercise‐induced angina pectoris: a double‐blind parallel‐group comparison of different classes of calcium channel blockers
1999
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
2005
A Healthcare Monitoring System for the Diagnosis of Heart Disease in the IoMT Cloud Environment Using MSSO-ANFIS
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
An integrated decision support system based on ANN and Fuzzy_AHP for heart failure risk prediction
2016
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic Dysfunction
2011
V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose
2013 Standout
Innate Immunity and the Failing Heart
2015
Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure
2007
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Morphological Integration and Developmental Modularity
2008 Standout
Interventions to improve the appropriate use of polypharmacy for older people
2014
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Heart Disease Identification Method Using Machine Learning Classification in E-Healthcare
2020 Standout
Works of Peter Dunselman being referenced
Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin
2009
Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade: Results of the Felodipine ER and Metoprolol CR in Angina (FEMINA) Study
1997
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics
2005
Predictors of fatal and non‐fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A‐1, high‐sensitivity C‐reactive peptide and N‐terminal pro B‐type natriuretic peptide
2009
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial
2009
Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
2009
Hemodynamic effects of metoprolol in acute myocardial infarction
1985